A pragmatic single-blind randomised controlled trial and health economic evaluation of leukotriene receptor antagonists in primary care at steps two and three of the national asthma guidelines
Completed
- Conditions
- AsthmaRespiratory
- Registration Number
- ISRCTN99132811
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 720
Inclusion Criteria
Not provided at time of registration.
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Need for further treatment intervention<br>2. Frequency of exacerbations<br>3. Short-acting beta agonist use<br>4. Hospitalisations<br>5. Time off work<br>6. Daily inhaled steroid dose (step three)<br>7. Asthma symptoms<br>8. Morning and diurnal variation in peak flow<br>9. Those with eczema/rhinitis comparative change in disease assessment
- Secondary Outcome Measures
Name Time Method ot provided at time of registration.